These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35045531)

  • 21. Vitamin E in the treatment of tardive dyskinesia.
    Akhtar S; Jajor TR; Kumar S
    J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment effects of vitamin E for tardive dyskinesia.
    Adler LA; Edson R; Lavori P; Peselow E; Duncan E; Rosenthal M; Rotrosen J
    Biol Psychiatry; 1998 Jun; 43(12):868-72. PubMed ID: 9627740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
    Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.
    Pardis P; Remington G; Panda R; Lemez M; Agid O
    J Psychopharmacol; 2019 Oct; 33(10):1187-1198. PubMed ID: 31347436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Treatments for Tardive Dyskinesia].
    Nomoto M
    Brain Nerve; 2022 May; 74(5):565-570. PubMed ID: 35589648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time for a New Slate in Tardive Dyskinesia Research.
    Blanchet PJ; Lévesque D
    Mov Disord; 2020 May; 35(5):752-755. PubMed ID: 32067258
    [No Abstract]   [Full Text] [Related]  

  • 29. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000209. PubMed ID: 10796508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal-Emergent Dyskinesia Related to Benztropine: A Case Report.
    Thalner S; Agrawal H
    WMJ; 2023 May; 122(2):143-145. PubMed ID: 37141483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tardive neuroleptic-induced dyskinesias].
    Zakharov DV; Buriak IV; Mihailov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):31-35. PubMed ID: 35175700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
    Dorevitch A; Lerner V; Shalfman M; Kalian M
    Int Clin Psychopharmacol; 1997 May; 12(3):171-3. PubMed ID: 9248874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2004; (1):CD000206. PubMed ID: 14973950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
    Dabiri LM; Pasta D; Darby JK; Mosbacher D
    Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.